128 related articles for article (PubMed ID: 10824927)
1. Amplification and overexpression of mdm2 gene in ependymomas.
Suzuki SO; Iwaki T
Mod Pathol; 2000 May; 13(5):548-53. PubMed ID: 10824927
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of MDM2 in pleomorphic xanthoastrocytomas.
Matsumoto K; Suzuki SO; Fukui M; Iwaki T
Pathol Int; 2004 Jun; 54(6):387-91. PubMed ID: 15144396
[TBL] [Abstract][Full Text] [Related]
3. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
4. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
[TBL] [Abstract][Full Text] [Related]
5. Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.
Korshunov A; Neben K; Wrobel G; Tews B; Benner A; Hahn M; Golanov A; Lichter P
Am J Pathol; 2003 Nov; 163(5):1721-7. PubMed ID: 14578171
[TBL] [Abstract][Full Text] [Related]
6. p53 Pathway dysfunction in primary childhood ependymomas.
Gaspar N; Grill J; Geoerger B; Lellouch-Tubiana A; Michalowski MB; Vassal G
Pediatr Blood Cancer; 2006 May; 46(5):604-13. PubMed ID: 16086408
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma.
Friedrich C; von Bueren AO; Kolevatova L; Bernreuther C; Grob T; Sepulveda-Falla D; van den Boom L; Westphal M; Simon R; Glatzel M
Childs Nerv Syst; 2016 Feb; 32(2):281-90. PubMed ID: 26686534
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
[TBL] [Abstract][Full Text] [Related]
9. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
11. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13.
Karakoula K; Suarez-Merino B; Ward S; Phipps KP; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Beck J; Thomas DG; Warr TJ
Genes Chromosomes Cancer; 2008 Nov; 47(11):1005-22. PubMed ID: 18663750
[TBL] [Abstract][Full Text] [Related]
12. Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.
Biernat W; Kleihues P; Yonekawa Y; Ohgaki H
J Neuropathol Exp Neurol; 1997 Feb; 56(2):180-5. PubMed ID: 9034372
[TBL] [Abstract][Full Text] [Related]
13. Alterations of protein 4.1 family members in ependymomas: a study of 84 cases.
Rajaram V; Gutmann DH; Prasad SK; Mansur DB; Perry A
Mod Pathol; 2005 Jul; 18(7):991-7. PubMed ID: 15731777
[TBL] [Abstract][Full Text] [Related]
14. Induction of MDM2-P2 transcripts correlates with stabilized wild-type p53 in betel- and tobacco-related human oral cancer.
Ralhan R; Sandhya A; Meera M; Bohdan W; Nootan SK
Am J Pathol; 2000 Aug; 157(2):587-96. PubMed ID: 10934161
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis for p53 and mdm2 in intracranial germ cell tumors.
Iwato M; Tachibana O; Tohma Y; Nitta H; Hayashi Y; Yamashita J
Acta Neuropathol; 2000 Jan; 99(1):21-5. PubMed ID: 10651023
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of epidermal growth factor receptor (EGFR) and MDM2 gene amplification and protein immunoreactivity in human glioblastomas.
Rieske P; Kordek R; Bartkowiak J; Debiec-Rychter M; Biernat W; Liberski PP
Pol J Pathol; 1998; 49(3):145-9. PubMed ID: 9810172
[TBL] [Abstract][Full Text] [Related]
18. The expression of p73, p21 and MDM2 proteins in gliomas.
Kamiya M; Nakazato Y
J Neurooncol; 2002 Sep; 59(2):143-9. PubMed ID: 12241107
[TBL] [Abstract][Full Text] [Related]
19. Mdm2 gene amplification in gastric cancer correlation with expression of Mdm2 protein and p53 alterations.
Günther T; Schneider-Stock R; Häckel C; Kasper HU; Pross M; Hackelsberger A; Lippert H; Roessner A
Mod Pathol; 2000 Jun; 13(6):621-6. PubMed ID: 10874665
[TBL] [Abstract][Full Text] [Related]
20. Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target.
Riemenschneider MJ; Knobbe CB; Reifenberger G
Int J Cancer; 2003 May; 104(6):752-7. PubMed ID: 12640683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]